These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1210 related articles for article (PubMed ID: 25037622)

  • 1. Use of balloon expandable transcatheter valves for valve-in-valve implantation in patients with degenerative stentless aortic bioprostheses: Technical considerations and results.
    Bapat V; Davies W; Attia R; Hancock J; Bolter K; Young C; Redwood S; Thomas M
    J Thorac Cardiovasc Surg; 2014 Sep; 148(3):917-22; discussion 922-4. PubMed ID: 25037622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of transcatheter heart valves for a valve-in-valve implantation in patients with degenerated aortic bioprosthesis: technical considerations and results.
    Bapat V; Attia R; Redwood S; Hancock J; Wilson K; Young C; Thomas M
    J Thorac Cardiovasc Surg; 2012 Dec; 144(6):1372-9; discussion 1379-80. PubMed ID: 23140962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transfemoral valve-in-valve implantation for degenerated bioprosthetic aortic valves using the new balloon-expandable Edwards Sapien 3 valve.
    Gonska B; Seeger J; Rodewald C; Scharnbeck D; Rottbauer W; Wöhrle J
    Catheter Cardiovasc Interv; 2016 Oct; 88(4):636-643. PubMed ID: 27142354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcatheter aortic valve implantation for treatment of patients with degenerated aortic bioprostheses--valve-in-valve technique.
    Gotzmann M; Mügge A; Bojara W
    Catheter Cardiovasc Interv; 2010 Dec; 76(7):1000-6. PubMed ID: 20824744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early clinical outcome of aortic transcatheter valve-in-valve implantation in the Nordic countries.
    Ihlberg L; Nissen H; Nielsen NE; Rück A; Busund R; Klaarborg KE; Soendergaard L; Harnek J; Miettinen H; Eskola M; Wahba A; Laine M
    J Thorac Cardiovasc Surg; 2013 Nov; 146(5):1047-54; discussion 1054. PubMed ID: 23998786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcatheter aortic valve implantation for high risk patients with severe aortic stenosis using the Edwards Sapien balloon-expandable bioprosthesis: a single centre study with immediate and medium-term outcomes.
    Osten MD; Feindel C; Greutmann M; Chamberlain K; Meineri M; Rubin B; Mezody M; Ivanov J; Butany J; Horlick EM
    Catheter Cardiovasc Interv; 2010 Mar; 75(4):475-85. PubMed ID: 19937781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcatheter aortic valve-in-valve treatment of degenerative stentless supra-annular Freedom Solo valves: A single centre experience.
    Cockburn J; Dooley M; Parker J; Hill A; Hutchinson N; de Belder A; Trivedi U; Hildick-Smith D
    Catheter Cardiovasc Interv; 2017 Feb; 89(3):438-444. PubMed ID: 27315455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgical sutureless and transcatheter aortic valves: hemodynamic performance and clinical outcomes in propensity score-matched high-risk populations with severe aortic stenosis.
    Kamperidis V; van Rosendael PJ; de Weger A; Katsanos S; Regeer M; van der Kley F; Mertens B; Sianos G; Ajmone Marsan N; Bax JJ; Delgado V
    JACC Cardiovasc Interv; 2015 Apr; 8(5):670-7. PubMed ID: 25946438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early experience of implantation of the new CoreValve(®) Evolut(™) in degenerated bioprosthetic aortic valves.
    Fairley SL; Jeganathan R; Manoharan G; Spence MS
    Catheter Cardiovasc Interv; 2014 Feb; 83(3):485-92. PubMed ID: 23857751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of patient-prosthesis mismatch after transcatheter aortic valve-in-valve implantation in degenerated bioprostheses.
    Seiffert M; Conradi L; Baldus S; Knap M; Schirmer J; Franzen O; Koschyk D; Meinertz T; Reichenspurner H; Treede H
    J Thorac Cardiovasc Surg; 2012 Mar; 143(3):617-24. PubMed ID: 22169448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Which available transapical transcatheter valve fits into degenerated aortic bioprostheses?
    Ferrari E; Marcucci C; Sulzer C; von Segesser LK
    Interact Cardiovasc Thorac Surg; 2010 Jul; 11(1):83-5. PubMed ID: 20395247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of paravalvular regurgitation after Edwards SAPIEN transcatheter aortic valve replacement: management of paravalvular regurgitation after TAVR.
    Martinez CA; Singh V; O'Neill BP; Alfonso CE; Bilsker MS; Martinez Clark P; Williams D; Cohen MG; Heldman AW; O'Neill WW
    Catheter Cardiovasc Interv; 2013 Aug; 82(2):300-11. PubMed ID: 23580318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term follow-up after aortic valve replacement with Edwards Prima Plus stentless bioprostheses in patients younger than 60 years of age.
    Christ T; Grubitzsch H; Claus B; Konertz W
    J Thorac Cardiovasc Surg; 2014 Jan; 147(1):264-9. PubMed ID: 23158257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcarotid aortic valve-in-valve implantation for degenerated stentless aortic root conduits with severe regurgitation: a case series.
    Huber C; Praz F; O'Sullivan CJ; Langhammer B; Gloekler S; Stortecky S; von Allmen RS; Meier B; Carrel T; Englberger L; Windecker S; Wenaweser P
    Interact Cardiovasc Thorac Surg; 2015 Jun; 20(6):694-700. PubMed ID: 25776924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcatheter aortic valve implantation for treatment of failing homograft with preexisting mechanical mitral prosthesis.
    Attia R; Bapat V
    Catheter Cardiovasc Interv; 2013 Aug; 82(2):324-7. PubMed ID: 22120953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Balloon-expandable prostheses for transcatheter aortic valve replacement.
    Ribeiro HB; Urena M; Allende R; Amat-Santos IJ; Rodés-Cabau J
    Prog Cardiovasc Dis; 2014; 56(6):583-95. PubMed ID: 24838134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First-in-human valve-in-valve implantation of a 20 mm balloon expandable transcatheter heart valve.
    Binder RK; Wood D; Webb JG; Cheung A
    Catheter Cardiovasc Interv; 2013 Dec; 82(7):E929-31. PubMed ID: 22821872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. European experience with the second-generation Edwards SAPIEN XT transcatheter heart valve in patients with severe aortic stenosis: 1-year outcomes from the SOURCE XT Registry.
    Schymik G; Lefèvre T; Bartorelli AL; Rubino P; Treede H; Walther T; Baumgartner H; Windecker S; Wendler O; Urban P; Mandinov L; Thomas M; Vahanian A
    JACC Cardiovasc Interv; 2015 Apr; 8(5):657-69. PubMed ID: 25946437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes Following Transcatheter Aortic Valve Replacement for Degenerative Stentless Versus Stented Bioprostheses.
    Duncan A; Moat N; Simonato M; de Weger A; Kempfert J; Eggebrecht H; Walton A; Hellig F; Kornowski R; Spargias K; Mendiz O; Makkar R; Guerrero M; Rihal C; George I; Don C; Iadanza A; Bapat V; Welsh R; Wijeysundera HC; Wood D; Sathananthan J; Danenberg H; Maisano F; Garcia S; Gafoor S; Nombela-Franco L; Cobiella J; Dvir D
    JACC Cardiovasc Interv; 2019 Jul; 12(13):1256-1263. PubMed ID: 31202944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prosthesis-Specific Predictors of Paravalvular Regurgitation after Transcatheter Aortic Valve Replacement: Impact of Calcification and Sizing on Balloon-Expandable versus Self-Expandable Transcatheter Heart Valves.
    Stähli BE; Nguyen-Kim TD; Gebhard C; Erhart L; Frauenfelder T; Tanner FC; Falk V; Landmesser U; Nietlispach F; Lüscher TF; Maier W; Binder RK
    J Heart Valve Dis; 2015 Jan; 24(1):10-21. PubMed ID: 26182615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 61.